Trials / Completed
CompletedNCT04532528
ReAHEAD: A Study to Find Out Whether Education Improves Adherence to Dabigatran in People With Atrial Fibrillation Who Are Younger Than 75 Years
Relationship of Advanced Holding Education and ADherence on Antithrombotic in Younger SPAF Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 897 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
Lifelong oral anticoagulant (OAC) therapy is the preferred treatment for the prevention of thromboembolic events in the majority of patients with Atrial Fibrillation (AF). Adherence to medication is essential for valid treatment for OAC therapy. The study aims to explore whether the advanced educational intervention would improve the adherence to dabigatran.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dabigatran | Dabigatran |
Timeline
- Start date
- 2020-08-27
- Primary completion
- 2023-05-08
- Completion
- 2023-05-08
- First posted
- 2020-08-31
- Last updated
- 2025-05-15
- Results posted
- 2024-09-19
Locations
23 sites across 1 country: Taiwan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04532528. Inclusion in this directory is not an endorsement.